Forte Biosciences, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
9.00 |
22.50 |
21.47 |
124.78 |
| Przychód Δ r/r |
0.00% |
0.00% |
inf% |
150.00% |
-4.57% |
481.15% |
| Przychód (min) |
0.00 |
0.00 |
9.00 |
22.50 |
21.47 |
124.78 |
| Przychód (max) |
0.00 |
0.00 |
9.00 |
22.50 |
21.47 |
124.78 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-43.71 |
-12.76 |
-9.62 |
-6.94 |
-6.24 |
-14.08 |
| Zysk netto % |
-inf% |
-inf% |
-106.92% |
-30.84% |
-29.06% |
-11.29% |
| EPS (średnia) |
-9.44 |
-4.38 |
-3.20 |
-2.38 |
-2.14 |
-4.83 |
| Liczba analityków (Przychody) |
0 |
0 |
4 |
3 |
1 |
2 |
| Liczba analityków (EPS) |
2 |
3 |
3 |
1 |
1 |
1 |
| symbol |
FBRX |
FBRX |
FBRX |
FBRX |
FBRX |
FBRX |